Sign in Subscribe
Class action lawsuits

Hims & Hers Health, Inc. Class Action Lawsuit Filed, Lead Plaintiff Deadline August 25, 2025

Strategic Insights

— 1 min read

Purchasers of common stock of Hims & Hers Health, Inc. (NYSE: HIMS) between April 29, 2025 and June 23, 2025, both dates inclusive, may be entitled to compensation due to alleged false and misleading statements made by the company during this period. The Rosen Law Firm, a global investor rights law firm, reminds investors of the lead plaintiff deadline of August 25, 2025. A class action lawsuit has already been filed against Hims & Hers Health, Inc.

Key Takeaways:

  • The lawsuit alleges that Hims & Hers Health, Inc. made false and misleading statements regarding its partnership with pharmaceutical company Novo Nordisk A/S and the availability of the weight-loss drug Wegovy.
  • The defendants allegedly failed to disclose that Novo approved of Hims' compounded semaglutide products under the "personalization" exception and that branded Wegovy would be offered alongside compounded semaglutide options on the Hims platform.
  • Investors who purchased Hims common stock during the Class Period may be entitled to compensation through a contingency fee arrangement.
  • The lead plaintiff deadline is August 25, 2025, and investors must move the Court to be considered for this position.

Statistics:

  • The Class Period ran from April 29, 2025 to June 23, 2025, both dates inclusive.
  • The lead plaintiff deadline is August 25, 2025.
  • The Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time.
  • In 2019, the firm secured over $438 million for investors.
  • In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar.

Sources:

  • Saint Joseph's College (Original source for the press release is not provided by Newsfile Corp. but was likely distributed through a newswire)
  • Hims & Hers Health, Inc. (NYSE: HIMS) investor relations website
  • The Rosen Law Firm, P.A. website (https://www.rosenlegal.com/)
  • Law360 (https://www.law360.com/)
  • LinkedIn: (https://www.linkedin.com/company/the-rosen-law-firm)
  • Twitter: (https://twitter.com/rosen_firm)
  • Facebook: (https://www.facebook.com/rosenlawfirm)

Read more